ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis, N Engl J Med, vol.370, issue.22, pp.2083-92, 2014. ,
Pirfenidone Clinical Study Group in Japan. Pirfenidone in idiopathic pulmonary fibrosis, Eur Respir J, 2010. ,
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis, Am J Respir Crit Care Med, vol.196, issue.6, pp.756-61, 2017. ,
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study, ERJ Open Res, vol.4, issue.4, pp.84-2018, 2018. ,
Analysis of lung function and survival in RECAP: an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis, vol.31, pp.198-205, 2014. ,
An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP), Respiration, vol.94, issue.5, pp.408-423, 2017. ,
, Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis, Chest, vol.148, issue.1, pp.196-201, 2015.
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials, Eur Respir J, vol.47, issue.1, pp.243-53, 2016. ,
Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study, PLoS One, vol.12, issue.1, p.166462, 2017. ,
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis -2017 update. Full-length version, Rev Mal Respir, vol.34, issue.8, pp.900-68, 2017.,
URL : https://hal.archives-ouvertes.fr/hal-01647076
, Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis, Eur Respir Rev, vol.26, issue.146, p.170057, 2017.
Longitudinal "real-world" outcomes of pirfenidone in idiopathic pulmonary fibrosis in Greece, vol.4, p.213, 2017. ,
Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: tolerability and adverse drug reactions, Respirology, vol.22, issue.6, pp.1171-1179, 2017. ,
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: an Italian real life study, Respir Med, 2015. ,
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases, Respiration, vol.88, issue.3, pp.199-207, 2014. ,